Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03123939
Title Phase III B in Acute Lymphoblastic Leukemia
Recruitment Completed
Gender
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: child | adult
Covered Countries NOR | ITA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.